Stock Price Forecast

May 2, 2022


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Heat Biologics Inc chart...

About the Company

Heat Biologics is a biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system. The company's gp96 platform is designed to activate immune responses against cancer or infectious diseases. The Company has multiple product candidates in development leveraging the gp96 platform, including HS-110, which has completed enrollment in its Phase 2 trial, and a COVID-19 vaccine program in preclinical development. In addition, Heat Biologics is also developing a pipeline of proprietary immunomodulatory antibodies and cell-based therapies, including PTX-35 and HS-130 in Phase 1 clinical trials.

CEO

Jeffrey Wolf

Exchange

NYSE MKT LLC

Website

www.heatbio.com

$2M

Total Revenue

39

Employees

$60M

Market Capitalization

-1.69

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $HTBX News

Heat Biologics Takes Beating After Pricing $12 Million Stock Offering

5y ago, source: TheStreet.com

Heat Biologics Inc. nosedived after the Durham, North Carolina-based biopharmaceutical company filed for a share offering pricing expected to hit $12 million. Heat Biologics Inc. nosedived after ...

Heat Biologics Announces Research Collaboration with University of Miami to Develop Vaccine Designed to Protect Against COVID-19 Coronavirus

4y ago, source: Yahoo Finance

2020 / Heat Biologics, Inc. (HTBX), a clinical-stage biopharmaceutical company specialized in the development of therapeutic vaccines, announced today a strategic collaboration with the University ...

Heat Biologics Announces Significant Expansion of R&D and Pre-Clinical Capabilities at Corporate Headquarters

17d ago, source: ADVFN

Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple ...

Heat Biologics, Inc. Submits Revised Protocol to FDA for Phase 2 Clinical Study of HS-110 for the Treatment of Non-Small Cell Lung Cancer

10y ago, source: Yahoo Finance

CHAPEL HILL, NC--(Marketwired - Mar 19, 2014) - Heat Biologics, Inc. (NASDAQ: HTBX), a clinical stage biopharmaceutical company focused on the development of novel cancer immunotherapies, announced ...

Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110

17d ago, source: ADVFN

Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced promising ...

HCWB HCW Biologics Inc.

17d ago, source: Seeking Alpha

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases.

Scorpius Holdings, Inc. Announces Pricing of Public Offering

21d ago, source: Business Insider

About Scorpius Holdings, Inc. Scorpius Holdings Inc. is an integrated ... For Investor Relations Inquiries: Heat Biologics NewsMORE Related Stocks ...

Scorpius Holdings, Inc. Announces Proposed Public Offering of Common Stock

21d ago, source: Business Insider

About Scorpius Holdings, Inc. Scorpius Holdings Inc. is an integrated ... For Investor Relations Inquiries: Heat Biologics NewsMORE Related Stocks ...

ADMA Biologics Inc ADMA

4d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Heat Biologics, Inc. Submits Revised Protocol to FDA for Phase 2 Clinical Study of HS-110 for the Treatment of Non-Small Cell Lung Cancer

10y ago, source: Yahoo UK & Ireland

CHAPEL HILL, NC--(Marketwired - Mar 19, 2014) - Heat Biologics, Inc. (NASDAQ: HTBX), a clinical stage biopharmaceutical company focused on the development of novel cancer immunotherapies ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...